Solid Biosciences
SLDB
SLDB
67 hedge funds and large institutions have $39.5M invested in Solid Biosciences in 2022 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 11 increasing their positions, 23 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
52% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 23
52% less capital invested
Capital invested by funds: $83.2M → $39.5M (-$43.6M)
Holders
67
Holding in Top 10
–
Calls
$65K
Puts
$12K
Top Buyers
1 | +$1.79M | |
2 | +$712K | |
3 | +$417K | |
4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$293K |
5 |
E
Ergoteles
New York
|
+$158K |
Top Sellers
1 | -$3.08M | |
2 | -$1.82M | |
3 | -$1.33M | |
4 |
IC
Ikarian Capital
Dallas,
Texas
|
-$625K |
5 |
State Street
Boston,
Massachusetts
|
-$453K |